Patents by Inventor Yawen DING

Yawen DING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220298139
    Abstract: A compound represented by formula I are provided. The stereoisomer, racemate, tautomer, isotopic label, prodrug or a pharmaceutically acceptable salt of the compound, and a pharmaceutical composition containing the compound, a preparation method, and medical use of the compound are further provided. The structure is as shown in formula I.
    Type: Application
    Filed: September 23, 2020
    Publication date: September 22, 2022
    Inventors: Guozhong YE, Chenli DING, Yawen DING, Qian HE, Chaodong WANG
  • Patent number: 11345679
    Abstract: A quaternary lactam compound of formula (I). The compound is used in the manufacture of a medicament for the treatment and/or prevention of thrombotic or thromboembolic disorders.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: May 31, 2022
    Assignee: SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD.
    Inventors: Shanghai Yu, Yan Feng, Shiqiang Li, Xiaolin Wang, Zhilong Hu, Yawen Ding, Feihong Dai, Qian He, Chaodong Wang
  • Publication number: 20210032219
    Abstract: A quaternary lactam compound of formula (I). The compound is used in the manufacture of a medicament for the treatment and/or prevention of thrombotic or thromboembolic disorders.
    Type: Application
    Filed: March 29, 2019
    Publication date: February 4, 2021
    Inventors: Shanghai YU, Yan FENG, Shiqiang LI, Xiaolin WANG, Zhilong HU, Yawen DING, Feihong DAI, Qian HE, Chaodong WANG